Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre of Medical Genetics, |
RCV002246043 | SCV002025372 | uncertain significance | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PM2, PM8, PP4 |
Victorian Clinical Genetics Services, |
RCV002246043 | SCV005398558 | likely pathogenic | Marfan syndrome | 2020-10-19 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Likely pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with FBN1-related disease. Variants predicted to result in nonsense mediated decay cause loss of function effects, and are more commonly associated with severe Marfan syndrome (MIM#154700). Missense variants with both dominant negative and loss of function effects on protein function, are also associated with causing Marfan syndrome and additionally, ectopia lentis (MIM#129600) (OMIM, PMID: 29357934). The exact genotype-phenotype correlation for this gene is still unclear, and is compounded by variable expressivity (GeneReviews). (I) 0108 - This gene is associated with both recessive and dominant disease. Patients with a recessive form of disease have Marfan syndrome, however there are very few reports (OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity. The genotype-phenotype correlations for this gene are unclear, with single variants reported in patients with a range of phenotypes (GeneReviews, OMIM). (I) 0212 - Non-canonical splice site variant without proven consequence on splicing (no functional evidence available). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0505 - Abnormal splicing predictions by in silico tools are conflicting but affected nucleotide is highly conserved. (I) 0710 - Another splice variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. A splice variant at the same nucleotide position (c.5917+5G>T) has been reported as a VUS in a patient with Marfan syndrome (ClinVar). (I) 0802 - This variant has moderate previous evidence of pathogenicity in an unrelated individual. This variant has been classified as pathogenic and reported in a patient with Marfan syndrome (PMID: 11826022), and a de novo patient with cardiac defects, ectopia lentis and arachnodactyly (Decipher). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed) (VCGS #18G003425, 18G004342). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |